Skip to main content
Clinical Trials/NCT01846338
NCT01846338UnknownNot Applicable

The Effect of「GTT-EGCG」on Acne Women

National Yang Ming Chiao Tung University1 site in 1 country80 target enrollmentStarted: October 1, 2012Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Enrollment
80
Locations
1
Primary Endpoint
acne lesion counts

Study Overview

Brief Summary

The aim of this study is to investigate the therapeutic effects of green tea extract on acne treatment and related hormone peptides by a double-blinded, randomized and controlled clinical trial.

Detailed Description

change in acne lesions counts, hormone, quality of life

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
20 Years to 45 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Female patient
  • •20 to 45 years of age
  • •moderate or severe acne vulgaris as defined by the Investigator's Global Assessment (IGA; score of 3 or 4 on a scale from 0 to 5)

Exclusion Criteria

  • •Received systemic retinoid or hormone treatment in the previous 3 months.
  • •Abnormal liver enzymes or kidney function tests (1.5 times higher than the upper normal limit)
  • •abnormal blood chemistry
  • •Pregnant or breast feeding women or the intention of becoming pregnant
  • •Concurrent systemic illness
  • •Very severe acne(IGA score5)

Arms & Interventions

green tea extract EGCG

Experimental

experimental: green tea extract EGCG, 500mg , tid, 4 weeks

Intervention: green tea extract EGCG (Dietary Supplement)

cellulose

Placebo Comparator

Placebo Comparator: cellulose, 500 mg tid, 4 weeks

Intervention: green tea extract EGCG (Dietary Supplement)

Outcomes

Primary Outcomes

acne lesion counts

Time Frame: four weeks

Secondary Outcomes

  • quality of life, SF-12(four weeks)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Chung-Hua Hsu

Associated Professor

National Yang Ming Chiao Tung University

Study Sites (1)

Loading locations...

Similar Trials